The Evaluation of the Obstetric Outcomes in Re-Pregnancy after Recovery from Peripartum Cardiomyopathy: Obstetric Outcomes in Re-Pregnancy after Recovery from Peripartum Cardiomyopathy

Sajjad  Khan; Sumera  Begum; Munazza  Ayoub; Jabbar  Ali; Lubna  Tahir; Sheer  Bahadar Khan

doi:10.54393/pbmj.v5i7.688

Authors

Sajjad Khan FCPS (Cardiology) MO Cardiology Unit Timergara Teaching Hospital Dir Lower
Sumera Begum FCPS (Gynae and Obs) WMO Gynae unit Timergara Teaching hospital Dir Lower KPK
Munazza Ayoub FCPS (Gynae and OBS) WMO Gynae unit Timergara Teaching Hospital Dir Lower KPK
Jabbar Ali FCPS (Cardiology) Assistant professor MTI LRH Peshawar KPKP
Lubna Tahir FCPS (Gynae and Obs) District specialist Timergara Teaching Hospital Dir Lower
Sheer Bahadar Khan FCPS (Cardiology) Associate professor MTI, LRH Peshawar KPK

DOI:

https://doi.org/10.54393/pbmj.v5i7.688

Keywords:

Re-pregnancy, Peripartum cardiomyopathy, LV ejection, neonatal outcomes and echocardiography examination

Abstract

The exceptional form of pregnancy specific idiopathic congestive heart failure is known as peripartum cardiomyopathy. Its onset is highly observed during the last month of pregnancies. Objective: To evaluate the cardiac outcomes in the subsequent pregnancies of patients having history of the cardiomyopathy. Methods: It is a retrospective cohort study conducted at Gynae unit Timergara Teaching hospital Dir Lower KPK for the duration of one year from March 2021 to March 2022. The seventy six patients that had history of peripartum cardiomyopathy with re-pregnancy were selected for the study. The participants were aware of the study and written consent was signed by them. The echocardiography examination of each patients were reviewed. The demographic data maternal and neonatal outcomes data of index was recorded. The SPSS software was used for the statistical analysis of the data. Results: Data of seventy six patients that had history of peripartum cardiomyopathy with re-pregnancy were evaluated. The average age of mother at the time of delivery was 26 years. There were 30 patients that reported about mood disorders and they were already taking medications during the pregnancy. 15 patients reported about migraine headache. There were only small number of patients that had prior diagnosis of cardiovascular diseases. The chronic hypertension was observed in 3 patients and 4 patients had Wolf-Parkinson-White syndrome. Conclusions: In this study the effect of re-pregnancy on cardiac outcomes were studied among patients who had a history of peripartum cardiomyopathy. Patients having peripartum cardiomyopathy history and recover LV function are at risk for a transient minor decrease in LV ejection fraction during future pregnancies. The promising obstetric and neonatal outcomes were observed.

References

Elkayam U. Risk of subsequent pregnancy in women with a history of peripartum cardiomyopathy. Journal of the American College of Cardiology. 2014 Oct; 64(15):1629-36. doi: 10.1016/j.jacc.2014.07.961.

Habli M, O'Brien T, Nowack E, Khoury S, Barton JR, Sibai B. Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome. American journal of obstetrics and gynecology. 2008 Oct; 199(4):415.e1-5. doi: 10.1016/j.ajog.2008.06.087

McNamara DM, Elkayam U, Alharethi R, Damp J, Hsich E, Ewald G, Modi K, et al. Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy). Journal of the American College of Cardiology. 2015 Aug; 66(8):905-14. doi: 10.1016/j.jacc.2015.06.1309

Canobbio MM, Warnes CA, Aboulhosn J, Connolly HM, Khanna A, Koos BJ, et al. Management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2017 Feb; 135(8):e50-87. doi: 10.1161/CIR.0000000000000458

Hu J, Ye Y, Lu A, Chen L, Mai Y, Huang G, et al. Pregnancy Outcomes in Patients With Heart Disease in China. The American journal of cardiology. 2020 Jun; 125(11):1718-1724. doi: 10.1016/j.amjcard.2020.02.043

Son SL, Hosek LL, Stein MC, Allshouse AA, Catino AB, Hoskoppal AK, et al. Association between pregnancy and long-term cardiac outcomes in individuals with congenital heart disease. American Journal of Obstetrics and Gynecology. 2022 Jan; 226(1):124.e1-124.e8. doi: 10.1016/j.ajog.2021.07.015

Murali S and Baldisseri MR. Peripartum cardiomyopathy. Critical care medicine. 2005 Oct; 33(10):S340-6. doi: 10.1097/01.CCM.0000183500.47273.8E

Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, et al. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. The New England Journal of Medicine. 2013 Oct; 369(14):1317-26. doi: 10.1056/NEJMoa1307684

Merlo M, Caiffa T, Gobbo M, Adamo L, Sinagra G. Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives. International Journal of Cardiology, Heart and Vasculature. 2018 Mar; 18:52-57. doi: 10.1016/j.ijcha.2018.02.005

Hameed A, Karaalp IS, Tummala PP, Wani OR, Canetti M, Akhter MW, et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. Journal of the American College of Cardiology. 2001 Mar; 37(3):893-9. doi: 10.1016/s0735-1097(00)01198-0

Elkayam U and Bitar F. Valvular heart disease and pregnancy: part II: prosthetic valves. Journal of the American College of Cardiology. 2005 Aug; 46(3):403-10. doi: 10.1016/j.jacc.2005.02.087

Khairy P, Ouyang DW, Fernandes SM, Lee-Parritz A, Economy KE, Landzberg MJ. Pregnancy outcomes in women with congenital heart disease. Circulation. 2006 Jan; 113(4):517-24. doi: 10.1161/CIRCULATIONAHA.105.589655.

Moak JP, Barron KS, Hougen TJ, Wiles HB, Balaji S, Sreeram N, et al. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. Journal of the American College of Cardiology. 2001 Jan; 37(1):238-42. doi: 10.1016/s0735-1097(00)01048-2

Tzemos N, Silversides CK, Colman JM, Therrien J, Webb GD, Mason J, et al. Late cardiac outcomes after pregnancy in women with congenital aortic stenosis. American Heart Journal. 2009 Mar; 157(3):474-80. doi: 10.1016/j.ahj.2008.10.020

Gulati M, Cooper-DeHoff RM, McClure C, Johnson BD, Shaw LJ, Handberg EM, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Archives of Internal Medicine. 2009 May; 169(9):843-50. doi: 10.1001/archinternmed.2009.50

Bhagra CJ, D'Souza R, Silversides CK. Valvular heart disease and pregnancy part II: management of prosthetic valves. Heart. 2017 Feb; 103(3):244-252. doi: 10.1136/heartjnl-2015-308199

Pieper PG, Balci A, Van Dijk AP. Pregnancy in women with prosthetic heart valves. Netherlands Heart Journal. 2008 Dec; 16(12):406-11. doi: 10.1007/BF03086187

Wald RM, Sermer M, Colman JM. Pregnancy in young women with congenital heart disease: Lesion-specific considerations. Paediatrics and Child Health. 2011 May; 16(5):e33-7. doi: 10.1093/pch/16.5.e33

Soma-Pillay P, Nene Z, Mathivha TM, Macdonald AP. The effect of warfarin dosage on maternal and fetal outcomes in pregnant women with prosthetic heart valves. Obstetric Medicine. 2011 Mar; 4(1):24-7. doi: 10.1258/om.2010.100067

Pezeshkian M, Imani S, Asl AA. Analysis of maternal-fetal outcomes of valvular heart surgeries in pregnant women. Zahedan Journal of Research in Medical Sciences. 2010 Apr; 12(1).

Garcez JD, Rosa VE, Lopes AS, Accorsi TA, Fernandes JR, Pomerantzeff PM, et al. Patient Management with Metallic Valve Prosthesis during Pregnancy and Postpartum Period. Arquivos Brasileiros Cardiologia. 2015 Oct; 105(4):426-9. doi: 10.5935/abc.20150130